Efficacy of Early Oral Switch with β-Lactams for Low-Risk Staphylococcus aureus Bacteremia-Reference-Cited by-同舟云学术

Efficacy of Early Oral Switch with β-Lactams for Low-Risk Staphylococcus aureus Bacteremia

Published:2020-06-23 Issue:7 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Bupha-Intr Olivia¹,Blackmore Tim¹²,Bloomfield Max¹²

Affiliation:

1. Department of Infection Services, Wellington Regional Hospital, Wellington, New Zealand

2. Department of Microbiology, Wellington Southern Community Laboratories, Wellington, New Zealand

Abstract

The aim of this study was to assess the safety of early oral switch (EOS) prior to 14 days for low-risk Staphylococcus aureus bacteremia (LR-SAB), which is the primary treatment strategy used at our institution. The usual recommended therapy is 14 days of intravenous (i.v.) antibiotics. All patients with SAB at our hospital were identified between 1 January 2014 and 31 December 2018. Those meeting low-risk criteria (health care-associated, no evidence of deep infection or demonstrated involvement of prosthetic material, and no further positive blood cultures after 72 h) were included in the study.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.02345-19

Reference34 articles.

1. Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults

2. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

3. Clinical management of Staphylococcus aureus bacteraemia

4. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

5. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial;The Lancet Infectious Diseases;2024-05

2. Uncomplicated Staphylococcus aureus bacteraemia: Partial oral treatment is comparable to fully intravenous treatment – A single centre retrospective cohort study;Clinical Infection in Practice;2024-01

3. Oral Antibiotics for Bacteremia and Infective Endocarditis: Current Evidence and Future Perspectives;Microorganisms;2023-12-18

4. One Small Step (Down) for Antibiotics, One Giant Leap for Outpatient Therapy: The Role of Oral Antibiotics in Serious Bacterial Infections;Current Infectious Disease Reports;2023-10-31

5. Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol;Clinical Infectious Diseases;2023-10-31